Differential modulation of cisplatin cytotoxicity by human ovarian carcinoma cell lines in vitro
Related Experiment Videos
S A Shellard1, A M Fichtinger-Schepman, L K Hosking
1Laboratory of Cellular Chemotherapy, Imperial Cancer Research Fund, Lincoln's Inn-Fields, London, UK.
Biochemical Society Transactions
|April 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma.
Bone marrow transplantation·2016
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients.
Bone marrow transplantation·2015
Fungal ADP-ribosylation: an emerging signalling pathway in adaptation and virulence.
Biochemical Society transactions·2026
Bacterial effectors targeting the host ubiquitin system.
Biochemical Society transactions·2026
Mechanisms of INO80 remodeling.
Biochemical Society transactions·2026
Novel chemogenetic approaches in modulating calcium signaling.
Biochemical Society transactions·2026
Migrasomes in kidney diseases: emerging molecular mechanisms, diagnostic value, and therapeutic prospects.
Biochemical Society transactions·2026
NINJ1-mediated membrane rupture bridges cell death to tissue inflammation.
Biochemical Society transactions·2026
DCST1 drives cisplatin resistance via non-canonical ubiquitination and stabilization of NFAT5 to suppress PANoptosis in bladder cancer.
Cell death and differentiation·2026
Advanced Anal Squamous Cell Carcinoma in the Chemoimmunotherapy Era: Retifanlimab, Nivolumab, and a Practical Framework for Treatment Selection.
Journal of gastrointestinal cancer·2026